No, Profound Medical Corp. does not pay cash dividends to its shareholders. As a commercial-stage medical technology enterprise, the company strategically reinvests all available capital, operational revenues, and financial reserves back into research and development, clinical trials, regulatory compliance, and global marketing initiatives aimed at expanding the commercial footprint of its therapeutic platforms.